Royal Bank of Canada
JSPRW

Royal Bank of Canada’s Japer Therapeutics Warrants JSPRW Stock Holding History

Royal Bank of Canada’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-372
Closed -$1K – 7557
2020
Q4 		$1K Hold
372
– – ﹤0.01% 6948
2020
Q3 		$0 Buy
372
+289
+348% +$292 ﹤0.01% 6780
2020
Q2 		$0 Buy
+83
New +$52 ﹤0.01% 6758

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $244M AUM 110.95% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Royal Bank of Canada's JSPRW Position: Q1 2021 in Review

Royal Bank of Canada sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2021, closing a stake of 372 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in JSPRW in Q2 2020 and held it in 3 quarters. The position peaked at $1K in Q4 2020. 26 funds tracked by Wall St. Rank hold JSPRW as of Q1 2021.

  • Royal Bank of Canada reported no remaining Japer Therapeutics Warrants position as of Q1 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 372 Japer Therapeutics Warrants shares in Q1 2021, an estimated $1K.
  • Royal Bank of Canada first reported a position in Japer Therapeutics Warrants in Q2 2020 and held it in 3 quarters.
  • Royal Bank of Canada's Japer Therapeutics Warrants position peaked at $1K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2021.

Based on Royal Bank of Canada's 13F filing for Q1 2021, filed 17 May 2021.